位置:成果数据库 > 期刊 > 期刊详情页
黄芪、苏木及其组方对荷瘤小鼠脾调节性T细胞表达及血清细胞因子水平的干预作用
  • ISSN号:1006-2157
  • 期刊名称:《北京中医药大学学报》
  • 时间:0
  • 分类:R285.5[医药卫生—中药学;医药卫生—中医学]
  • 作者机构:[1]中国中医科学院广安门医院肿瘤科,北京100053
  • 相关基金:国家自然科学基金资助项目(No.30672764)
中文摘要:

目的观察黄芪、苏木及其组方对荷瘤小鼠脾CD4+CD25+Foxp3+调节性T细胞表达及血清细胞因子水平的干预作用。方法复制C57BL/6小鼠Lewis肺癌动物模型,动态观察黄芪、苏木及其组方对抑瘤率、肺转移抑制率、荷瘤小鼠体重、生存期的影响。接种后6、10、15、20d流式细胞仪检测荷瘤小鼠脾CD4+CD25+Foxp3+调节性T细胞的表达,20d采集小鼠血清,流式微球阵列技术检测细胞因子IL-2、IL-6、IL-10、IL-12p70、IFN-γ水平,酶联免疫法(ELISA)法检测转化生长因子β(TGF-β)水平。结果苏木组6d、黄芪+苏木组10d瘤重低于荷瘤对照组(P〈0.05);黄芪+苏木组肺转移抑制率为77.75%;荷瘤对照组小鼠脾CD4+CD25+Foxp3+细胞表达随荷瘤天数的增加呈上升趋势,20d黄芪组小鼠脾CD4+CD25+Foxp3+细胞表达低于荷瘤对照组(P〈0.05),黄芪+苏木组显著低于荷瘤对照组(P〈0.01);黄芪+苏木组小鼠血清IL-10、TGF-β水平低于荷瘤对照组(P〈0.05);中位生存期分别为黄芪+苏木组(39d)〉黄芪组(38d)〉苏木组(35d)〉荷瘤对照组(24d)。结论益气活血中药组方黄芪+苏木可通过调控荷瘤小鼠脾细胞中调节性T细胞表达改善其体内存在的免疫耐受状态,其作用优于单一益气药或活血药,这可能是中药抑制小鼠Lewis肺癌生长转移、延长生存的作用靶点之一。

英文摘要:

Objective To observe the interventional effects of Huangqi (Radix Astragali) and Sumu (Lignum Sappan) and their formulas on expression of spleen CD4+CD25+Foxp3+ regulatory T cells (Treg) and serum level of cytokines in tumor-bearing mice.Methods The model of Lewis pulmonary cancer was established in C57BL/6 mice.The influences of Huangqi,Sumu and their formulas on the tumor inhibitory rate,inhibitory rate of lung metastasis,weight and survival time were observed dynamically in tumor-bearing mice.The expression of CD4+CD25+Foxp3+ Treg detected by using flow cytometer 6,10,15 and 20 days after inoculation respectively.The levels of IL-2,IL-6,IL-10,IL-12p70 and IFN-γ were detected by using CBA FLEX SET and the level of TGF-β was detected by using ELISA.Results The tumor weight was lower in 6-day Sumu group and 10-day Huangqi+Sumu group than that in the control group (P0.05).The inhibitory rate of lung metastasis was 77.75% in Huangqi+Sumu group.The expression of spleen CD4+CD25+Foxp3+ Treg trended to ascend along with the increase of tumor-bearing day in the control group,and that was lower in 20-day Huangqi group (P0.05) and significantly lower in Huangqi+Sumu group (P0.01) than that in the control group.The serum levels of IL-10 and TGF-β were lower in Huangqi+Sumu group than those in the control group (P0.05).The descending order of median survival time showed as follows:Huangqi+Sumu group (39 days),Huangqi group (38 days),Sumu group (35 days) and control group (24 days).Conclusion The compound formula (Huangqi+Sumu) with the actions of supplementing qi and activating blood circulation can improve the immune tolerance condition through regulating the expression of spleen Treg in tumor-bearing mice,with the better effect than single Huangqi or Sumu.It may be one of effective targets of Chinese herbal remedies for inhibiting Lewis lung metastasis and prolonging life.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《北京中医药大学学报》
  • 中国科技核心期刊
  • 主管单位:中华人民共和国教育部
  • 主办单位:北京中医药大学
  • 主编:王永炎
  • 地址:北京市北三环东路11号
  • 邮编:100029
  • 邮箱:jbutcm@yahoo.com.cn
  • 电话:010-64287405
  • 国际标准刊号:ISSN:1006-2157
  • 国内统一刊号:ISSN:11-3574/R
  • 邮发代号:82-414
  • 获奖情况:
  • 1989年获全国高等医药学院校学报编辑质量优秀学报...,1990年获北京高等学校自然科学学报优秀编辑质量一等奖,1995年获北京市高校系统自然科学学报优秀学报一等奖,1995年获国家中医药管理局颁发的全国中医药优秀期...,1996年获中共中央宣传部、国家科学技术委员会、新...,2000年获国家中医药管理局颁发的全国中医药优秀期...,中国期刊方阵“双效”期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),美国乌利希期刊指南,日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),中国北大核心期刊(2000版)
  • 被引量:32130